← FDA Drug Approvals (Drugs@FDA)

MIDOSTAURIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS · Approved 2024-04-29

Drug application

FDA Application #

ANDA216076

Application type

Abbreviated New Drug Application (Generic)

Brand name

MIDOSTAURIN

Generic name

Midostaurin

Active ingredients

MIDOSTAURIN

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

TEVA PHARMS

First approval

2024-04-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown